Filter Results:
(2,715)
Show Results For
- All HBS Web
(5,668)
- People (18)
- News (2,029)
- Research (2,715)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,995)
Show Results For
- All HBS Web
(5,668)
- People (18)
- News (2,029)
- Research (2,715)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,995)
Sort by
- Article
We Have a Rare Opportunity to Create a Stronger, More Equitable Society
By: Shai Davidai, Martin Day, Daniela Goya-Tocchetto, Oliver Hauser, Jon M. Jachimowicz, M. Usman Mirza, Nailya Ordabayeva, L. Taylor Phillips, Barnabas Szaszi and Stephanie Tepper
Income inequality in the United States was at historic levels before the coronavirus hit. Now, as the disease—and the social and economic implications it brings—spread across the country, it is likely to create even deeper fissures between the poor and rich. View Details
Keywords: Socioeconomic Status; Coronavirus; Inequality; Work; Income; Equality and Inequality; Health Pandemics; Gender; Money; Policy; Race; Society
Davidai, Shai, Martin Day, Daniela Goya-Tocchetto, Oliver Hauser, Jon M. Jachimowicz, M. Usman Mirza, Nailya Ordabayeva, L. Taylor Phillips, Barnabas Szaszi, and Stephanie Tepper. "We Have a Rare Opportunity to Create a Stronger, More Equitable Society." Behavioral Scientist (June 1, 2020).
- 02 Apr 2010
- What Do You Think?
Why Are Fewer and Fewer U.S. Employees Satisfied With Their Jobs?
effects on productivity, (5) Job design that allows employees to have control over their work is conducive to lower stress levels and better health outcomes (for example, the higher one rises in an organization, the lower the risk of... View Details
Keywords: by Jim Heskett
- December 5, 2024
- Article
A Consensus Definition of Creativity in Surgery: A Delphi Study Protocol
By: Alex Thabane, Tyler McKechnie, Phillip Staibano, Vikram Arora, Goran Calic, Jason W. Busse, Sameer Parpia and Mohit Bhandari
Introduction
Clear definitions are essential in science, particularly in the study of abstract phenomena like creativity. Due to its inherent complexity and domain-specific nature, the study of creativity has been complicated, as evidenced by the various... View Details
Clear definitions are essential in science, particularly in the study of abstract phenomena like creativity. Due to its inherent complexity and domain-specific nature, the study of creativity has been complicated, as evidenced by the various... View Details
Thabane, Alex, Tyler McKechnie, Phillip Staibano, Vikram Arora, Goran Calic, Jason W. Busse, Sameer Parpia, and Mohit Bhandari. "A Consensus Definition of Creativity in Surgery: A Delphi Study Protocol." PLoS ONE 19, no. 12 (December 5, 2024).
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)
- Article
Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures.
By: Ariel Dora Stern
The use of biomarkers holds great promise for the development of new therapeutics and the acceleration of clinical research. However, biomarkers must be validated—a complex and costly endeavor. Importantly, biomarker validation is meaningfully shaped by economic and... View Details
Stern, Ariel Dora. "Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures." Journal of Law, Medicine & Ethics 47, no. 3 (September 2019): 396–397.
- November 1978 (Revised October 1989)
- Case
Amicon Corp. (B)
Details the negotiation between Amicon and three potential licensees, Jackson, Maynard-Smith and Behrstein. View Details
Keywords: Technology; Patents; Negotiation Process; Negotiation Participants; Health Care and Treatment; Biotechnology Industry
Capon, Noel. "Amicon Corp. (B)." Harvard Business School Case 579-094, November 1978. (Revised October 1989.)
- 02 Aug 2016
- First Look
August 2, 2016
Healthcare Partners Inc. (DaVita), in August 2013. The two would discuss whether Golomb should lead a new DaVita venture, Paladina Health (Paladina), which operated a network of primary care clinics. DaVita... View Details
Keywords: Sean Silverthorne
- November 24, 2020
- Article
4 Strategies to Make Telehealth Work for Elderly Patients
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
As providers have ramped up their use of telehealth during the COVID-19 pandemic, one group—the elderly—has experienced particular challenges in adopting the technologies. This article describes the strategies four innovative provider organizations have used to engage... View Details
Keywords: Telehealth; Health Pandemics; Health Care and Treatment; Internet and the Web; Age; Technology Adoption; Strategy
Ikram, Umar, Susanna Gallani, Jose F. Figueroa, and Thomas W. Feeley. "4 Strategies to Make Telehealth Work for Elderly Patients." Harvard Business Review Digital Articles (November 24, 2020).
- 2024
- Working Paper
Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances
By: Amar Bhidé and Srikant M. Datar
In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details
Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms
Bhidé, Amar, and Srikant M. Datar. "Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 21-035, August 2020. (Revised May 2024.)
- January 2018
- Case
Spark Therapeutics: Pioneering Gene Therapy
By: Robert F. Higgins and Tina Liu
Spark Therapeutics is a pioneering gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed. The company is considering an initial public... View Details
Keywords: Health Care and Treatment; Innovation and Invention; Business Startups; Opportunities; Problems and Challenges; Strategy
Higgins, Robert F., and Tina Liu. "Spark Therapeutics: Pioneering Gene Therapy." Harvard Business School Case 818-059, January 2018.
- April 2017
- Supplement
Imprimis (C)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details
Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (C)." Harvard Business School Supplement 717-497, April 2017.
- 16 Dec 2011
- Research & Ideas
Reintroducing Intellectual Ambition to the Study of Business History
Business historians can profit from careful analyses of government and personal archives to reconstruct the early "start-up" phases of firms—and to uncover the role that other organizational forms, such as partnerships, played... View Details
Keywords: by Geoffrey Jones & Walter Friedman
- 19 Mar 2007
- Research & Ideas
Handicapping the Best Countries for Business
competitiveness of her exports and the costs of her imported inputs. In a microeconomic sense, the business person also cares about tariffs (which affect trade), industrial policies, tax policies (on... View Details
Keywords: by Sean Silverthorne
- 11 Nov 2014
- First Look
First Look: November 11
2014 and again in 2015. Publisher's link: http://hbr.org/2014/11/digital-ubiquity-how-connections-sensors-and-data-are-revolutionizing-business/ar/1 November 2014 Harvard Business Review How Not to Cut Health View Details
Keywords: Sean Silverthorne
- April 2024 (Revised July 2024)
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details
Keywords: Cost vs Benefits; Decisions; Judgments; Values and Beliefs; Global Strategy; Health Care and Treatment; Patents; Growth and Development Strategy; Growth Management; Product Positioning; Supply and Industry; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Philanthropy and Charitable Giving; Opportunities; Social Issues; Equality and Inequality; Health Industry; Health Industry; Denmark; United States; Europe; China; India; Middle East; North Africa
Badaracco, Joseph L., Tom Quinn, and John Schultz. "Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs." Harvard Business School Case 324-114, April 2024. (Revised July 2024.)
- 20 Jan 2016
- Research & Ideas
Maybe Uber isn't God's Gift to Mankind
Whither Uber? Competitive Dynamics in Transportation Networks. “I’m trying to counterbalance the many papers that exult in how fabulous Uber is, and how it’s practically God’s gift to mankind,” Edelman says. Forthcoming in the journal Competition View Details
- 24 Apr 2007
- First Look
First Look: April 24, 2007
Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=307069 Note on U.S. Public Education Finance (B): Expenditures Harvard Business School Note 307-070 Describes the cost structure and spending policies of... View Details
Keywords: Sean Silverthorne
- May 4, 2023
- Article
Falling Insulin Prices—What Just Happened?
By: Leemore S. Dafny
Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details
Keywords: Price; Health Care and Treatment; Public Opinion; Demand and Consumers; Pharmaceutical Industry
Dafny, Leemore S. "Falling Insulin Prices—What Just Happened?" New England Journal of Medicine 388, no. 18 (May 4, 2023): 1636–1639.
- 04 May 2007
- What Do You Think?
How Do Managers Think?
Summing Up Can managers acquire ways of thinking or ways of learning from doctors? Managers can learn from an understanding of how doctors think. But whether the lessons are profound or even totally applicable was a matter of discussion among respondents to this... View Details
Keywords: by Jim Heskett
- 02 Mar 2010
- First Look
First Look: March 2
Andrew Huang and the Center had worked with the Taiwan National Health Insurance system to create a pay-for-performance reimbursement program for breast cancer care that has since been adopted by five other... View Details
Keywords: Martha Lagace